Medicare Enrolled
Dr. Sandeep Gulati, D.O.
Neurology · Bronx, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gulati from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gulati?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gulati
Dr. Sandeep Gulati is a neurology specialist in Bronx, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gulati performed 1,151 Medicare services across 808 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gulati received a total of $119,735 from 88 pharmaceutical and/or device companies across 2047 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gulati is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 26% volume in NY
$119,735 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,151
Medicare services
Top 26% in NY for neurology
808
Unique beneficiaries
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~61 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
305 | $80 | $200 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
196 | $114 | $300 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
187 | $91 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
110 | $150 | $350 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
88 | $120 | $450 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
55 | $196 | $800 |
| Annual depression screening | 50 | $22 | $75 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
49 | $13 | $50 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
39 | $229 | $2,800 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $51 | $75 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
20 | $72 | $125 |
| New patient office visit, complex (60-74 min) | 17 | $205 | $350 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
11 | $57 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$119,735
Total received (2018-2024)
Avg $17,105/year across 7 years
Top 6% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
2,047
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$88,736 (74.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$30,999 (25.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$33,835
2023
$26,443
2022
$21,230
2021
$26,819
2020
$3,490
2019
$4,274
2018
$3,644
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$22,661
ABBVIE INC.
$6,814
MDD US Operations, LLC
$590
Lundbeck LLC
$498
PFIZER INC.
$415
SK Life Science, Inc.
$300
Otsuka America Pharmaceutical, Inc.
$268
Lilly USA, LLC
$219
Novartis Pharmaceuticals Corporation
$218
Amneal Pharmaceuticals LLC
$207
Alexion Pharmaceuticals, Inc.
$163
Neurelis, Inc.
$153
Kyowa Kirin, Inc.
$149
Genentech USA, Inc.
$142
Teva Pharmaceuticals USA, Inc.
$117
ARGENX US, INC.
$109
Biogen, Inc.
$93
Amgen Inc.
$84
Grifols USA, LLC
$81
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$75
Eisai Inc.
$74
UCB, Inc.
$65
Neurocrine Biosciences, Inc.
$59
Takeda Pharmaceuticals U.S.A., Inc.
$53
Abbott Laboratories
$47
REVANCE THERAPEUTICS, INC.
$33
Vanda Pharmaceuticals Inc.
$30
TG Therapeutics, Inc.
$25
Alnylam Pharmaceuticals Inc.
$24
Curonix LLC
$23
Medtronic, Inc.
$17
AstraZeneca Pharmaceuticals LP
$15
SCILEX PHARMACEUTICALS INC.
$14
Top 3 companies account for 88.9% of 2024 payments
All-time payments by company (2018-2024) ›
EMD Serono, Inc.
$36,697
ABBVIE INC.
$31,976
AbbVie Inc.
$19,246
Allergan, Inc.
$2,648
Teva Pharmaceuticals USA, Inc.
$2,031
Novartis Pharmaceuticals Corporation
$1,875
Biogen, Inc.
$1,817
Amneal Pharmaceuticals LLC
$1,717
Lundbeck LLC
$1,186
Alexion Pharmaceuticals, Inc.
$1,103
SK Life Science, Inc.
$1,039
Avanir Pharmaceuticals, Inc.
$958
PFIZER INC.
$945
Lilly USA, LLC
$908
MDD US Operations, LLC
$828
Otsuka America Pharmaceutical, Inc.
$789
Celgene Corporation
$779
Kyowa Kirin, Inc.
$778
UCB, Inc.
$776
Adamas Pharmaceuticals, Inc.
$759
Amgen Inc.
$757
Neurocrine Biosciences, Inc.
$691
Allergan Inc.
$561
Sunovion Pharmaceuticals Inc.
$514
Neurelis, Inc.
$485
Janssen Pharmaceuticals, Inc
$445
ACADIA Pharmaceuticals Inc
$395
Abbott Laboratories
$365
Supernus Pharmaceuticals, Inc.
$344
Biohaven Pharmaceuticals, Inc.
$340
Alnylam Pharmaceuticals Inc.
$335
Biohaven Pharmaceutical Holding Company Ltd.
$326
GENZYME CORPORATION
$322
Grifols USA, LLC
$314
Genentech USA, Inc.
$313
US WorldMeds, LLC
$303
ARGENX US, INC.
$229
Medtronic USA, Inc.
$226
Acorda Therapeutics, Inc
$220
GE HEALTHCARE
$220
Eisai Inc.
$208
Mallinckrodt Enterprises LLC
$184
IDORSIA PHARMACEUTICALS US INC
$138
Currax Pharmaceuticals LLC
$137
GE HealthCare
$133
CSL Behring
$132
Impax Laboratories, Inc.
$130
Horizon Therapeutics plc
$125
ITI, Inc.
$119
Alfasigma USA, Inc.
$104
Sumitomo Pharma America, Inc.
$100
Takeda Pharmaceuticals U.S.A., Inc.
$97
Avion Pharmaceuticals
$93
Corium, LLC
$86
E.R. Squibb & Sons, L.L.C.
$84
Shire North American Group Inc
$79
Boston Scientific Corporation
$77
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$75
Mallinckrodt LLC
$68
Vanda Pharmaceuticals Inc.
$68
Almatica Pharma LLC
$59
AstraZeneca Pharmaceuticals LP
$59
CATALYST PHARMACEUTICALS, INC.
$56
Baxter Healthcare
$55
SCILEX PHARMACEUTICALS INC.
$53
Promius Pharma LLC
$53
Assertio Therapeutics, Inc.
$49
Medtronic, Inc.
$48
Life Molecular Imaging Ltd
$46
ARBOR PHARMACEUTICALS, INC.
$46
Scilex Pharmaceuticals Inc.
$45
Akcea Therapeutics, Inc.
$44
REVANCE THERAPEUTICS, INC.
$33
TG Therapeutics, Inc.
$25
BOSTON SCIENTIFIC CORPORATION
$24
Curonix LLC
$23
Kedrion Biopharma Inc.
$23
MITSUBISHI TANABE PHARMA AMERICA, INC.
$22
Mallinckrodt Hospital Products Inc.
$22
UPSHER-SMITH LABORATORIES LLC
$20
IMPEL PHARMACEUTICALS INC.
$19
GRT US Holding, Inc.
$18
Bausch Health US, LLC
$17
Vertical Pharmaceuticals, LLC
$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Xeris Pharmaceuticals, Inc.
$16
Aprecia Pharmaceuticals, LLC
$15
Upsher-Smith Laboratories LLC
$14
Top 3 companies account for 73.4% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Albuked · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · CAMBIA · CAPLYTA · COMIRNATY · CONTRAVE · COPAXONE · CREXONT · Cambia · Cenobamate · DAXXIFY · DUOPA · Dhivy · EMGALITY · FIRDAPSE · Fycompa · GENERAL DBS · GILENYA · GOCOVRI · GRALISE · GVOKE PFS · Gamunex-C · Gocovri · HETLIOZ · HYQVIA · Hillrom - Carnation Ambulatory Monitor · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INTELLIS ADAPTIVESTIM · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYDAYIS · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · PERCEPT PC BRAINSENSE · PLEGRIDY · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · Qutenza · RADICAVA · RELISTOR · REXULTI · REYVOW · RYTARY · Rebif · SKYCLARYS · SOLIRIS · SPINRAZA · SYNERGY · Soliris · Solitaire · Spritam · TECFIDERA · TEGSEDI · TOSYMRA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIIBRYD · VRAYLAR · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · XCOPRI · Xadago · Xience Alpine cornary stent system · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOMIG · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (74%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for neurology in NY.
Geographic Context
Neurologists within 10 mi
1,261
Per 100K population
88.8
County median income
$49,036
Nearest hospital
MONTEFIORE MOUNT VERNON HOSPITAL
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gulati is a clinical cardiology specialist, with above-average Medicare volume (top 26% in NY), with speaking/promotional industry engagement in the top 6% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gulati experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Gulati performed 305 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gulati receive payments from pharmaceutical companies?
Yes. Dr. Gulati received a total of $119,735 from 88 companies across 2,047 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gulati's costs compare to other neurologists in Bronx?
Dr. Gulati's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gulati) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Bronx
Browse neurologists in Bronx ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology